1. Home
  2. IMA vs GF Comparison

IMA vs GF Comparison

Compare IMA & GF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMA
  • GF
  • Stock Information
  • Founded
  • IMA 2019
  • GF 1990
  • Country
  • IMA United States
  • GF Germany
  • Employees
  • IMA N/A
  • GF N/A
  • Industry
  • IMA Biotechnology: Biological Products (No Diagnostic Substances)
  • GF Investment Managers
  • Sector
  • IMA Health Care
  • GF Finance
  • Exchange
  • IMA Nasdaq
  • GF Nasdaq
  • Market Cap
  • IMA 159.1M
  • GF 188.5M
  • IPO Year
  • IMA N/A
  • GF N/A
  • Fundamental
  • Price
  • IMA $9.14
  • GF $11.51
  • Analyst Decision
  • IMA
  • GF
  • Analyst Count
  • IMA 0
  • GF 0
  • Target Price
  • IMA N/A
  • GF N/A
  • AVG Volume (30 Days)
  • IMA 41.0K
  • GF 28.1K
  • Earning Date
  • IMA 01-01-0001
  • GF 01-01-0001
  • Dividend Yield
  • IMA N/A
  • GF 0.82%
  • EPS Growth
  • IMA N/A
  • GF N/A
  • EPS
  • IMA N/A
  • GF N/A
  • Revenue
  • IMA $4,300,000.00
  • GF N/A
  • Revenue This Year
  • IMA N/A
  • GF N/A
  • Revenue Next Year
  • IMA N/A
  • GF N/A
  • P/E Ratio
  • IMA N/A
  • GF N/A
  • Revenue Growth
  • IMA N/A
  • GF N/A
  • 52 Week Low
  • IMA $7.95
  • GF $7.38
  • 52 Week High
  • IMA $23.28
  • GF $9.41
  • Technical
  • Relative Strength Index (RSI)
  • IMA N/A
  • GF 44.64
  • Support Level
  • IMA N/A
  • GF $11.39
  • Resistance Level
  • IMA N/A
  • GF $11.59
  • Average True Range (ATR)
  • IMA 0.00
  • GF 0.17
  • MACD
  • IMA 0.00
  • GF -0.00
  • Stochastic Oscillator
  • IMA 0.00
  • GF 37.10

About IMA ImageneBio Inc. Common Stock

ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.

About GF New Germany Fund Inc. (The)

NEW GERMANY FUND INC is a non-diversified, closed-end management investment company. As the investment objective, the fund seeks long-term capital appreciation through investment in middle-market German equities. The fund's portfolio of investment includes investments in different sectors such as the industrials, information technology, material, consumer discretionary, Communication Services, Financials, Consumer Staples, Real Estate, Utilities, Healthcare, Energy, and others. Its portfolio is geographically diversified across the Netherlands, Germany, and Luxembourg.

Share on Social Networks: